Advancing the management of primary immunodeficiency diseases in Latin America: Latin American Society for Immunodeficiencies (LASID) Initiatives

Allergologia et Immunopathologia

Volumn 40, Issue 3, 2012, Pages 187-193

  Condino Neto, A ^a   Franco, J L ^b   Espinosa Rosales, F J ^c   Leiva, L E ^d   King, A ^e   Porras, O ^f   Oleastro, M ^g   Bezrodnik, L ^h   Grumach, A S ⁱ   Costa Carvalho, B T ^j   Sorensen, R U ^d,k  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HOSPITAL LUIS CALVO MACKENNA   (Chile)

^f HOSPITAL NACIONAL DE NIÑOS   (Costa Rica)

^g HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^h HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

ⁱ FACULDADE DE MEDICINA DO ABC   (Brazil)

^j FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^k UNIVERSIDAD DE LA FRONTERA   (Chile)

more..

Author keywords

Genetic disorders; Immunoglobulins; Latin America; Primary immunodeficiency; Recurrent infections

Indexed keywords

IMMUNOGLOBULIN;

ARGENTINA; ARTICLE; HEALTH CARE SYSTEM; IMMUNE DEFICIENCY; MEDICAL EDUCATION; MEDICAL PRACTICE; PHYSICIAN; SOUTH AND CENTRAL AMERICA; TREATMENT OUTCOME;

CONGRESSES AS TOPIC; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LATIN AMERICA; SOCIETIES, MEDICAL;

EID: 84860580633     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2012.01.003     Document Type: Article

References (34)

1. Wood P.M. Primary antibody deficiency syndromes. Curr Opin Hematol 2010, 17:356-361.
2. Pirofsky B. Intravenous immune globulin therapy in hypogammaglobulinemia. A review. Am J Med 1984, 76:53-60.
3. Cunningham-Rundles C., Siegal F.P., Smithwick E.M., Lion-Boulé A., Cunningham-Rundles S., O'Malley J., et al. Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. Ann Intern Med 1984, 101:435-439.
4. Busse P.J., Razvi S., Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002, 109:1001-1004.
5. Ochs H.D., Pinciaro P.J. Octagam 5%, an intravenous IgG product, is efficacious and well tolerated in subjects with primary immunodeficiency diseases. J Clin Immunol 2004, 24:309-314. Octagam Study Group.
6. Krasovec S., Ornani A., Oleastro M., Rosenzweig S., Roy A., Perez L., et al. Efficacy and tolerability of an Argentine intravenous immunoglobulin in pediatric patients with primary immunodeficiency diseases. J Clin Immunol 2007, 27:227-232.
7. Hagan J.B., Fasano M.B., Spector S., Wasserman R.L., Melamed I., Rojavin M.A., et al. Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency. J Clin Immunol 2010, 30:734-745.
8. Berger M., Murphy E., Riley P., Bergman G.E. Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G. South Med J 2010, 103:856-863. VIRTUE Trial Investigators.
9. Kaveri S.V., Maddur M.S., Hegde P., Lacroix-Desmazes S., Bayry J. Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy. Clin Exp Immunol 2011, 164(Suppl 2):2-5.
10. Stiehm E.R., Orange J.S., Ballow M., Lehman H. Therapeutic use of immunoglobulins. Adv Pediatr 2010, 57:185-218.
11. Orange J.S., Grossman W.J., Navickis R.J., Wilkes M.M. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clin Immunol 2010, 137:21-30.
12. Yong P.L., Boyle J., Ballow M., Boyle M., Berger M., Bleesing J., et al. Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: a working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology. Clin Immunol 2010, 135:255-263.
13. Orange J.S., Hossny E.M., Weiler C.R., Ballow M., Berger M., Bonilla F.A., et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy. Asthma and Immunology. J Allergy Clin Immunol 2006, 117(4 Suppl):S525-S553.
14. Errante P.R., Franco J.L., Espinosa-Rosales F.J., Sorensen R., Condino-Neto A. Advances in primary immunodeficiency diseases in Latin America: epidemiology and perspectives. Ann NY Acad Sci 2012, 1250:62-72.
15. Costa-Carvalho B.T., Condino-Neto A., Sole D., Filho N.R. I Consenso Brasileiro sobre o Uso de Imunoglobulina Humana em Pacientes com Imunodeficiências Primárias. Rev bras alerg imunopatol 2010, 33:104-116.
16. Geha R.S., Notarangelo L.D., Casanova J.L., Chapel H., Conley M.E., Fischer A., et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007, 120:776-794.
17. Tangsinmankong N., Bahna S.L., Good R.A. The immunologic workup of the child suspected of immunodeficiency. Ann Allergy Asthma Immunol 2001, 87:362-369.
18. Wood P. Primary antibody deficiency syndromes. Ann Clin Biochem 2009, 46:99-108.
19. Crago S.S., Murphy S.J. Common problems in the diagnosis of immunodeficiency in children. Monaldi Arch Chest Dis 1995, 50:453-458.
20. Matamoros Florí N., Mila Llambi J., Español Boren T., Raga Borga S., Fontan Casariego G. Primary immunodeficiency syndrome in Spain: first report of the National Registry in Children and Adults. J Clin Immunol 1997, 17:333-339.
21. Immune Deficiency Foundation. IDF Survey Reveals New Statistics-Diagnosis of PIDD Approximately 250,000 in U.S. 2007., accessed May 11, 2011. http://www.primaryimmune.org/publications/newsletter/idf_newsletter56_fall07.pdf.
22. Maródi L., Casanova J.L. Primary immunodeficiency diseases: the J Project. Lancet 2009, 373:2179-2181.
23. Pickett D., Modell V., Leighton I., Modell F. Impact of a physician education and patient awareness campaign on the diagnosis and management of primary immunodeficiencies. Immunol Res 2008, 40:93-94.
24. Modell V. The impact of physician education and public awareness on early diagnosis of primary immunodeficiencies: Robert A. Good Immunology Symposium. Immunol Res 2007, 38:43-47.
25. Zelazko M., Carneiro-Sampaio M., Cornejo de Luigi M., Garcia de Olarte D., Porras Madrigal O., Berrón Perez R., et al. Primary immunodeficiency diseases in Latin America: first report from eight countries participating in the LAGID. Latin American Group for Primary Immunodeficiency Diseases. J Clin Immunol 1998, 18:161-166.
26. Leiva L.E., Zelazco M., Oleastro M., Carneiro-Sampaio M., Condino-Neto A., Costa-Carvalho B.T., et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol 2007, 27:101-108.
27. Leiva L.E., Bezrodnik L., Oleastro M., Condino-Neto A., Costa-Carvalho B.T., Grumach A.S., et al. Primary immunodeficiency diseases in Latin America: proceedings of the second Latin American Society for Immunodeficiencies (LASID) Advisory Board. Allergol Immunopathol (Madr) 2011, 39:106-110.
28. Condino-Neto A., Franco J.L., Trujillo-Vargas C., Espinosa-Rosales F.J., Leiva L.E., Rodriguez-Quiroz F., et al. Critical issues and needs in management of primary immunodeficiency diseases in Latin America. Allergol Immunopathol (Madr) 2011, 39:45-51.
29. Costa-Carvalho B.T., Sole D., Sano F., Rosario N., Condino-Neto A., Boyle M., et al. Allergist-immunologist perspectives on primary immunodeficiency in Brazil. Presented at AAAAI Annual Meeting, March 18-22 2011.
30. Kanegae M.P.P., dos Santos A.M.N., Cavalcanti C.M., Condino-Neto A. Triagem neonatal para imunodeficiencia combinada grave. Rev bras alerg imunopatol 2011, 34:7-11.
31. Fasth A., Nyström J. Quality of life and health-care resource utilization among children with primary immunodeficiency receiving home treatment with subcutaneous human immunoglobulin. J Clin Immunol 2008, 28:370-378.
32. Boyle M.L., Scalchunes C. Impact of intravenous immunoglobulin (IVIG) treatment among patients with primary immunodeficiency diseases. Pharm Policy Law 2008, 10:133-146.
33. Aghamohammadi A., Montazeri A., Abolhassani H., Saroukhani S., Pouriabbar S., Tavassoli M., et al. Health-related quality of life in primary antibody deficiency. Iran J Allergy Asthma Immunol 2011, 10:47-51.
34. World PI Week. Global PI call to action., accessed May 11, 2011. http://www.worldpiweek.org/articles/global-pi-call-action.